Despite an upcoming manager retirement, Janus Henderson Venture remains on strong footing; the strategy earns Above Average People and Process ratings.
Janus Henderson Venture Fund Class T JAVTX
- NAV / 1-Day Return 94.08 / −1.08 %
- Total Assets 3.4B
-
Adj. Expense Ratio
0.920%
- Expense Ratio 0.900%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 24%
USD | NAV as of Jun 17, 2026 | 1-Day Return as of Jun 17, 2026, 12:11 AM GMT+0
Morningstar’s Analysis JAVTX
Will JAVTX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the JAVTX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of JAVTX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Glaukos Corp | 2.70 | 91M | Healthcare |
Bloom Energy Corp Class A | 2.62 | 88M | Industrials |
Legence Corp Ordinary Shares - Class A | 2.05 | 69M | Industrials |
SPX Technologies Inc | 1.92 | 65M | Industrials |
Perimeter Solutions Inc | 1.89 | 64M | Basic Materials |
Casey's General Stores Inc | 1.88 | 63M | Consumer Cyclical |
Bel Fuse Inc Class B | 1.88 | 63M | Technology |
OSI Systems Inc | 1.85 | 62M | Technology |
Tower Semiconductor Ltd | 1.81 | 61M | Technology |
Ligand Pharmaceuticals Inc | 1.77 | 60M | Healthcare |
United States